Cadrenal Therapeutics, Inc. Common Stock (CVKD) vs Paranovus Entertainment Technology Ltd. (PAVS)
A side-by-side comparison of Cadrenal Therapeutics, Inc. Common Stock and Paranovus Entertainment Technology Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$0.96HealthcareDelayed quote: Oct 6, 2026, 12:45 PM EDT
PAVS
Paranovus Entertainment Technology Ltd.
$3.77HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — CVKD vs PAVS
growth of $100 · dividends reinvested · last 4yCVKD -98.5% (-64.8%/yr)PAVS -100.0% (-95.1%/yr)CVKD compounded faster over this window
Log scale — wide-divergence pair
CVKD PAVS
CVKD vs PAVS: by the numbers
- •CVKD is the larger company ($3M vs $3M market cap).
- •Both run net losses; CVKD's is the smaller (0.00% vs -87.20% net margin).
Metrics side by side
Valuation
| Metric | CVKD | PAVS |
|---|---|---|
| P/B ratio | 0.84 | 0.10 |
Profitability
| Metric | CVKD | PAVS |
|---|---|---|
| Gross margin | 0.00% | 16.54% |
| Operating margin | 0.00% | -23.11% |
| Net margin | 0.00% | -87.20% |
| ROE | -282.13% | -40.75% |
| ROIC | -284.81% | -9.72% |
Growth (annualized)
| Metric | CVKD | PAVS |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -27.22% |
| Total return CAGR (5Y) | N/A | -92.96% |
Go deeper
Dig into the metrics
Cadrenal Therapeutics, Inc. Common Stock ROEParanovus Entertainment Technology ROECadrenal Therapeutics, Inc. Common Stock operating marginParanovus Entertainment Technology operating marginCadrenal Therapeutics, Inc. Common Stock revenue growthParanovus Entertainment Technology revenue growthCadrenal Therapeutics, Inc. Common Stock free cash flowParanovus Entertainment Technology free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.